Clearwater has supported Uniphar Group on the identification of its recent strategic acquisition of Durbin, a specialist supplier of pharmaceuticals based in the US and UK.
Headquartered in Dublin, Ireland, Uniphar Group is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access, and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK, the Benelux and the US.
Established over 50 years ago, Durbin is a specialist supplier of pharmaceuticals. The company sources and distributes products and its key focus is on the creation of exclusive market access programmes for global pharmaceutical and biotech companies.
Durbin, which supplies more than 160 countries, will be integrated into Uniphar’s Product Access division, growing the unit to more than 170 employees and managing access programmes for 36 global manufacturers.
